BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,005,503 | -15.4% | 53,140 | +2.2% | 0.00% | 0.0% |
| Q2 2023 | $2,369,484 | -1.2% | 52,008 | -12.0% | 0.00% | -25.0% |
| Q1 2023 | $2,397,217 | -29.9% | 59,103 | -11.9% | 0.00% | -20.0% |
| Q4 2022 | $3,417,743 | -1.1% | 67,054 | +4.5% | 0.01% | -16.7% |
| Q3 2022 | $3,457,000 | -9.5% | 64,173 | +8.0% | 0.01% | 0.0% |
| Q2 2022 | $3,818,000 | -42.5% | 59,441 | -30.6% | 0.01% | -33.3% |
| Q1 2022 | $6,643,000 | +19.2% | 85,669 | +32.0% | 0.01% | +28.6% |
| Q4 2021 | $5,572,000 | -68.4% | 64,914 | -70.4% | 0.01% | -74.1% |
| Q3 2021 | $17,650,000 | +326.9% | 219,449 | +327.3% | 0.03% | +440.0% |
| Q2 2021 | $4,134,000 | -17.1% | 51,355 | -13.1% | 0.01% | -16.7% |
| Q1 2021 | $4,984,000 | -31.7% | 59,090 | -35.0% | 0.01% | +20.0% |
| Q4 2020 | $7,298,000 | -30.7% | 90,936 | -31.9% | 0.01% | -70.6% |
| Q3 2020 | $10,529,000 | -42.8% | 133,568 | -37.5% | 0.02% | -48.5% |
| Q2 2020 | $18,400,000 | +15.1% | 213,696 | +13.5% | 0.03% | -2.9% |
| Q1 2020 | $15,992,000 | -50.8% | 188,295 | -51.6% | 0.03% | -35.8% |
| Q4 2019 | $32,514,000 | -87.7% | 388,838 | -87.3% | 0.05% | -88.6% |
| Q3 2019 | $263,488,000 | +38.5% | 3,066,317 | +32.0% | 0.46% | +34.4% |
| Q2 2019 | $190,286,000 | -9.6% | 2,323,399 | -10.2% | 0.35% | -7.7% |
| Q1 2019 | $210,383,000 | +83.3% | 2,587,408 | +48.4% | 0.38% | +80.3% |
| Q4 2018 | $114,797,000 | -20.7% | 1,744,109 | -7.2% | 0.21% | -16.5% |
| Q3 2018 | $144,841,000 | +41882.9% | 1,878,850 | +40097.9% | 0.25% | +24800.0% |
| Q2 2018 | $345,000 | +133.1% | 4,674 | +105.5% | 0.00% | – |
| Q1 2018 | $148,000 | -8.1% | 2,274 | -8.3% | 0.00% | – |
| Q4 2017 | $161,000 | +3.9% | 2,481 | 0.0% | 0.00% | – |
| Q3 2017 | $155,000 | -92.8% | 2,481 | -93.1% | 0.00% | -100.0% |
| Q2 2017 | $2,154,000 | -42.6% | 35,817 | -50.1% | 0.00% | +33.3% |
| Q1 2017 | $3,752,000 | +177.1% | 71,810 | +135.0% | 0.00% | 0.0% |
| Q4 2016 | $1,354,000 | +144.8% | 30,554 | +162.9% | 0.00% | +200.0% |
| Q3 2016 | $553,000 | -14.9% | 11,621 | -19.3% | 0.00% | 0.0% |
| Q2 2016 | $650,000 | -71.8% | 14,394 | -74.3% | 0.00% | -80.0% |
| Q1 2016 | $2,308,000 | -23.6% | 55,918 | -29.3% | 0.01% | -16.7% |
| Q4 2015 | $3,020,000 | -65.9% | 79,138 | -70.6% | 0.01% | -68.4% |
| Q3 2015 | $8,850,000 | -95.7% | 269,399 | -90.8% | 0.02% | -95.4% |
| Q2 2015 | $207,985,000 | -29.0% | 2,943,886 | -31.1% | 0.41% | -28.6% |
| Q1 2015 | $292,952,000 | +37.4% | 4,273,541 | +46.9% | 0.57% | +36.8% |
| Q4 2014 | $213,266,000 | -99.8% | 2,909,888 | +64.2% | 0.42% | +146.5% |
| Q3 2014 | $127,179,887,000 | -7.0% | 1,772,048 | -6.3% | 0.17% | 0.0% |
| Q2 2014 | $136,798,036,000 | -0.3% | 1,892,089 | +1.5% | 0.17% | +9.7% |
| Q1 2014 | $137,213,383,000 | -2.8% | 1,864,819 | -8.1% | 0.16% | -11.9% |
| Q4 2013 | $141,119,593,000 | +8.4% | 2,029,038 | +2.4% | 0.18% | -44.3% |
| Q3 2013 | $130,149,627,000 | – | 1,981,270 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |